Abstract
In prostatic cancer the frequency of osseous metastases - detected earliest by bone scintigraphy - amounts to 21.8% at the time of histological verification of the primary tumour. This frequency depends on the histological type of the prostatic carcinoma and yields 10.5% in uniform adenocarcinomas and 40.4% in pluriform carcinomas. The rate of metastases in the uniform adenocarcinomas rises with increasing histological dedifferentiation. The percentage of prostatic carcinomas with pluriform pattern in comparison with uniform adenocarcinomas rises markedly, corresponding to the local tumour extent (T2 = 36.4%, T3 = 52.2%, T4 = 61.1%). For the purpose of stage-related therapy of prostatic cancer, histological grading and clinical staging, including bone scanning, are absolutely essential.
| Original language | English |
|---|---|
| Pages (from-to) | 11-15 |
| Number of pages | 5 |
| Journal | Schweizerische Medizinische Wochenschrift |
| Volume | 110 |
| Issue number | 1 |
| State | Published - 1980 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Osseous metastases in prostatic cancer with reference to histologic type and local tumour stage'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver